University of Kiel

About: University of Kiel is a education organization based out in Kiel, Germany. It is known for research contribution in the topics: Population & Crystal structure. The organization has 27816 authors who have published 57114 publications receiving 2061802 citations. The organization is also known as: Christian Albrechts University & Christian-Albrechts-Universität zu Kiel.

Clay mineral-organic interactions

Abstract: Organic compounds can interact with clay minerals by i) adsorption at the external surfaces, ii) adsorption at the external and internal surfaces, iii) by exchange of exchangeable ions at the external surfaces, iv) by exchange of exchangeable ions at the external and internal surfaces, and v) by grafting reactions with silanol and aluminol groups leading to covalent bonds. Kaolin minerals intercalate only are a limited number of compounds whereas the reactions of 2:1 clay minerals, in particular smectites and vermiculites, are very manifold. Special attention is given to the interaction with neutral organic molecules such as alcohols, fatty acids, amines, amino acids, aromatic compounds, macrocyclic compounds, and nuclein bases. The interaction with complexes and dyes also provides the basis of advanced applications of clay minerals. Binding of long chain alkylammonium ions is a fundamental reaction for hydrophobising clay mineral particles as needed in many applications. The interaction of clay minerals with polymers including proteins is not only an actual field of research but also of practical importance. Organo-clay minerals are used as effective adsorbents. As these materials also adsorb solvent molecules together with the adsorptive, the adsorption process must be considered as adsorption from binary solution which, therefore, is also described in this chapter.

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Abstract: BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a multi-stage GWAS of 11,705 BRCA1 carriers (of whom 5,920 were diagnosed with breast and 1,839 were diagnosed with ovarian cancer), with a further replication in an additional sample of 2,646 BRCA1 carriers. We identified a novel breast cancer risk modifier locus at 1q32 for BRCA1 carriers (rs2290854, P = 2.7 x 10(-8), HR = 1.14, 95% CI: 1.09-1.20). In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4 x 10(-8), HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4 x 10(-8), HR = 1.20, 95% CI: 1.17-1.38). The 4q32.3 locus was not associated with ovarian cancer risk in the general population or BRCA2 carriers, suggesting a BRCA1-specific association. The 17q21.31 locus was also associated with ovarian cancer risk in 8,211 BRCA2 carriers (P = 2 x 10(-4)). These loci may lead to an improved understanding of the etiology of breast and ovarian tumors in BRCA1 carriers. Based on the joint distribution of the known BRCA1 breast cancer risk-modifying loci, we estimated that the breast cancer lifetime risks for the 5% of BRCA1 carriers at lowest risk are 28%-50% compared to 81%-100% for the 5% at highest risk. Similarly, based on the known ovarian cancer risk-modifying loci, the 5% of BRCA1 carriers at lowest risk have an estimated lifetime risk of developing ovarian cancer of 28% or lower, whereas the 5% at highest risk will have a risk of 63% or higher. Such differences in risk may have important implications for risk prediction and clinical management for BRCA1 carriers.

A New Approach to Markov-Switching GARCH Models

Abstract: The use of Markov-switching models to capture the volatility dynamics of financial time series has grown considerably during past years, in part because they give rise to a plausible interpretation of nonlinearities. Nevertheless, GARCH-type models remain ubiquitous in order to allow for nonlinearities associated with time-varying volatility. Existing methods of combining the two approaches are unsatisfactory, as they either suffer from severe estimation difficulties or else their dynamic properties are not well understood. In this article we present a new Markov-switching GARCH model that overcomes both of these problems. Dynamic properties are derived and their implications for the volatility process discussed. We argue that the disaggregation of the variance process offered by the new model is more plausible than in the existing variants. The approach is illustrated with several exchange rate return series. The results suggest that a promising volatility model is an independent switching GARCH process with a possibly skewed conditional mixture density.

Highly efficient reversible Z-E photoisomerization of a bridged azobenzene with visible light through resolved S(1)(n pi*) absorption bands.

Abstract: The reversible Z−E photoswitching properties of the (Z) and (E) isomers of the severely constrained bridged azobenzene derivative 5,6-dihydrodibenzo[c,g][1,2]diazocine (1) were investigated quantitatively by UV/vis absorption spectroscopy in solution in n-hexane. In contrast to normal azobenzene (AB), 1 has well separated S1(nπ*) absorption bands, peaking at λZ = 404 nm and λE = 490 nm. Using light at λ = 385 nm, it was found that 1Z can be switched to 1E with very high efficiency, Γ = 92 ± 3%. Conversely, 1E can be switched back to 1Z using light at λ = 520 nm with ∼100% yield. The measured quantum yields are ΦZ→E = 72 ± 4% and ΦE→Z = 50 ± 10%. The thermal lifetime of the (E) isomer is 4.5 ± 0.1 h at 28.5 °C. The observed photochromic and photoswitching properties of 1 are much more favorable than those for normal AB, making our title compound a promising candidate for interesting applications as a molecular photoswitch especially at low temperatures. The severe constraints by the ethylenic bridge appare...

Interleukin-6 Family Cytokines

Abstract: The interleukin (IL)-6 family cytokines is a group of cytokines consisting of IL-6, IL-11, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin 1 (CT-1), cardiotrophin-like cytokine (CLC), and IL-27. They are grouped into one family because the receptor complex of each cytokine contains two (IL-6 and IL-11) or one molecule (all others cytokines) of the signaling receptor subunit gp130. IL-6 family cytokines have overlapping but also distinct biologic activities and are involved among others in the regulation of the hepatic acute phase reaction, in B-cell stimulation, in the regulation of the balance between regulatory and effector T cells, in metabolic regulation, and in many neural functions. Blockade of IL-6 family cytokines has been shown to be beneficial in autoimmune diseases, but bacterial infections and metabolic side effects have been observed. Recent advances in cytokine blockade might help to minimize such side effects during therapeutic blockade.